文献速递结核与非结核分枝杆菌

肺结核的长期后遗症:叙述性综述

Long-term Sequelae of Pulmonary Tuberculosis: A Narrative Review.
PubMed 文献 · Clin Infect Dis · 2026-01-01

尽管化疗有效,肺结核幸存者仍面临长期后遗症相关的超额发病和死亡。超过半数治疗后的肺结核病例报告有通气功能障碍,约三分之一幸存者出现支气管扩张和慢性肺曲霉病。观察性数据显示结核与心血管疾病风险升高及肺癌风险增加相关,宿主炎症反应失调可能起关键作用但存在知识空白。

要点

  • 超过半数治疗后的肺结核病例存在通气功能障碍。
  • 约三分之一结核幸存者发生支气管扩张和慢性肺曲霉病。
  • 结核与心血管疾病及肺癌风险升高相关。

核心结论

  • 尽管化疗有效,肺结核幸存者仍经历与长期后遗症相关的超额发病和死亡。

研究设计与样本

  • 叙述性综述,讨论肺结核关键长期后遗症、研究重点及通过「Long TB Study」等新研究举措提出的前进方向。

主要发现

  • 超过半数治疗后的肺结核病例报告有气流阻塞、限制性和混合性通气缺陷。
  • 支气管扩张和慢性肺曲霉病在约三分之一结核幸存者中发生。
  • 观察性数据一致将结核与治疗期间及治疗后心血管疾病风险升高联系起来,包括心肌梗死、卒中和外周动脉疾病。
  • 结核与肺癌风险增加相关且独立于吸烟暴露,常见报告腺癌、鳞状细胞癌和小细胞癌。
  • 持续研究提示功能失调的宿主炎症反应在结核后遗症发病机制中起关键作用。

局限性

  • 存在多个知识空白,包括识别结核后遗症最高风险个体、定义临床相关表型、内型和自然史轨迹、识别预后生物标志物和免疫调节治疗的可改变靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite effective chemotherapy, tuberculosis (TB) survivors experience excess morbidity and mortality associated with long-term sequelae. Ventilatory defects, such as airflow obstruction, restriction, and mixed patterns, have been reported in over half of treated pulmonary TB cases. Spirometry alone underestimates burden, with impaired diffusing capacity, gas trapping, heterogeneous airway, and parenchymal damage on lung imaging, functional impairment, and persistent respiratory symptoms commonly reported. Bronchiectasis and chronic pulmonary aspergillosis are also common and occur in approximately one-third of TB survivors. Beyond the lungs, observational data consistently link TB to elevated cardiovascular disease risk, including myocardial infarction, stroke, and peripheral arterial disease, during and after TB treatment. Tuberculosis is also associated with increased lung cancer risk independent of smoking exposure, with adenocarcinoma, squamous cell, and small cell carcinomas commonly reported. While ongoing research suggests a key role of a dysfunctional host inflammatory response in the pathogenesis of TB sequelae, several knowledge gaps persist. Key among them include identifying individuals at highest risk of TB sequelae, defining clinically relevant phenotypes, endotypes, and natural history trajectories, and identifying prognostic biomarkers and potentially modifiable targets for immunomodulatory therapies. In this narrative review, we discuss key long-term sequelae of pulmonary TB, highlight research priorities, and propose a way forward through new research initiatives such as the "Long TB Study."

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Gupte AN, Boisson-Walsh A, Huaman MA, et al. Long-term Sequelae of Pulmonary Tuberculosis: A Narrative Review. Clin Infect Dis. 2026. PMID: 41974033. doi:10.1093/cid/ciag123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。